Importantly, several of these genes (e.g., IRF2, SLC38A1, CLEC2D) have been previously implicated as potential biomarkers or functional mediators in autoimmune or metabolic disorders, supporting their relevance for early detection strategies. The gene discussed is SLC38A1; the disease is metabolic disease.